News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6 Results
Type
Article (4)
Company Profile (1)
Press Release (1)
Section
Business (9)
News (5)
Tag
Alliances (1)
NextGen: Class of 2026 (5)
Pharmaceutical (1)
Startups (5)
Date
2024 (1)
2016 (2)
2015 (3)
Location
California (1)
Europe (1)
United States (1)
6 Results for "cadherx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
CadheRx
CadheRx Therapeutics, launched by Avalon Ventures and GSK, is discovering and developing therapeutic antibodies targeting soluble E-cadherin (sEcad) for the treatment of solid tumours including epithelial cancers.
Business
What You Need to Know About CadheRx
December 17, 2015
·
5 min read
Business
Avalon and GlaxoSmithKline Bankroll Three More Biotech Startups
June 15, 2015
·
3 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
·
15 min read
·
Mark Terry
Business
Iron Horse Therapeutics Launched By Avalon Ventures and GlaxoSmithKline
November 9, 2015
·
2 min read
Business
Avalon Ventures and COI Pharma Form New Company PDI Therapeutics to Develop Novel Immune-Oncology Therapies
May 20, 2016
·
4 min read
